House dust allergy and immunotherapy

Human Vaccines and Immunotherapeutics

Volumn 8, Issue 10, 2012, Pages 1469-1478

  Thomas, Wayne R ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Allergen; Asthma; Blomia; Cytokine; Dermatophagoides; House dust mite; IgE; IgG; Immunotherapy; T cell

Indexed keywords

EID: 84868268495     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.20812     Document Type: Review

References (157)

1. Simon D, Kernland Lang K. Atopic dermatitis: from new pathogenic insights toward a barrier-restoring and anti-inflammatory therapy. Curr Opin Pediatr 2011; 23:647-52; PMID:21970829; http://dx.doi. org/10.1097/MOP.0b013e32834cad0a.
2. BuBmann C, Bieber T, Novak N. Systemic therapeutic options for severe atopic dermatitis. J Dtsch Dermatol Ges 2009; 7:205-19; PMID:18759739; http://dx.doi. org/10.1111/j.1610-0387.2008.06834.x.
3. Mari A, Scala E, Alessandri C. The IgE-microarray testing in atopic dermatitis: a suitable modern tool for the immunological and clinical phenotyping of the disease. [Review]. Curr Opin Allergy Clin Immunol 2011; 11:438-44; PMID:21772137; http://dx.doi. org/10.1097/ACI.0b013e32834a41dd.
4. Meltzer EO, Blaiss MS, Derebery MJ, Mahr TA, Gordon BR, Sheth KK, et al. Burden of allergic rhinitis: results from the Pediatric Allergies in America survey. J Allergy Clin Immunol 2009; 124(Suppl):S43-70; PMID:19592081; http://dx.doi.org/10.1016/j. jaci.2009.05.013.
5. Rolla G, Guida G, Heffler E, Badiu I, Bommarito L, De Stefani A, et al. Diagnostic classification of persistent rhinitis and its relationship to exhaled nitric oxide and asthma: a clinical study of a consecutive series of patients. Chest 2007; 131:1345-52; PMID:17317733; http://dx.doi.org/10.1378/chest.06-2618.
6. Wijesinghe M, Weatherall M, Perrin K, Crane J, Beasley R. International trends in asthma mortality rates in the 5- to 34-year age group: a call for closer surveillance. Chest 2009; 135:1045-9; PMID:19349400; http://dx.doi.org/ 10.1378/chest.08-2082.
7. Lai CK, Beasley R, Crane J, Foliaki S, Shah J, Weiland S; International Study of Asthma and Allergies in Childhood Phase Three Study Group. Global variation in the prevalence and severity of asthma symptoms: phase three of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax 2009; 64:476- 83; PMID:19237391; http://dx.doi.org/10.1136/ thx.2008.106609.
8. Horak E, Lanigan A, Roberts M, Welsh L, Wilson J, Carlin JB, et al. Longitudinal study of childhood wheezy bronchitis and asthma: outcome at age 42. BMJ 2003; 326:422-3; PMID:12595380; http://dx.doi. org/10.1136/bmj.326.7386. 422.
9. Marks GB, Abramson MJ, Jenkins CR, Kenny P, Mellis CM, Ruffin RE, et al. Asthma management and outcomes in Australia: a nation-wide telephone interview survey. Respirology 2007; 12:212-9; PMID:17298453; http://dx.doi.org/10.1111/j. 1440-1843.2006.01010.x.
10. Friedman B, Berdahl T, Simpson LA, McCormick MC, Owens PL, Andrews R, et al. Annual report on health care for children and youth in the United States: focus on trends in hospital use and quality. Acad Pediatr 2011; 11:263-79; PMID:21640682; http://dx.doi. org/10.1016/j.acap.2011.04.002.
11. Sullivan PW, Ghushchyan VH, Slejko JF, Belozeroff V, Globe DR, Lin SL. The burden of adult asthma in the United States: evidence from the Medical Expenditure Panel Survey. J Allergy Clin Immunol 2011; 127:363-9, e1-3; PMID:21281868; http:// dx.doi.org/10.1016/j.jaci.2010.10.042.
12. Simpson A, Soderstrom L, Ahlstedt S, Murray CS, Woodcock A, Custovic A. IgE antibody quantification and the probability of wheeze in preschool children. J Allergy Clin Immunol 2005; 116:744- 9; PMID:16210045; http://dx.doi.org/10. 1016/j. jaci.2005.06.032.
13. Holt PG, Rowe J, Kusel M, Parsons F, Hollams EM, Bosco A, et al. Toward improved prediction of risk for atopy and asthma among preschoolers: a prospective cohort study. J Allergy Clin Immunol 2010; 125:653- 9, 659, e1-659, e7; PMID:20226300; http://dx.doi. org/10.1016/j.jaci.2009.12.018.
14. Lötvall J, Akdis CA, Bacharier LB, Bjermer L, Casale TB, Custovic A, et al. Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome. J Allergy Clin Immunol 2011; 127:355-60; PMID:21281866; http://dx.doi. org/10.1016/j.jaci.2010.11.037.
15. Thomas WR. Geography of house dust mite allergens. Asian Pac J Allergy Immunol 2010; 28:211-24; PMID:21337903.
16. Gruchalla RS, Pongracic J, Plaut M, Evans R 3rd, Visness CM, Walter M, et al. Inner City Asthma Study: relationships among sensitivity, allergen exposure, and asthma morbidity. J Allergy Clin Immunol 2005; 115:478-85; PMID:15753892; http://dx.doi. org/10.1016/j.jaci.2004.12.006.
17. Rönmark E, Bjerg A, Perzanowski M, Platts-Mills T, Lundbäck B. Major increase in allergic sensitization in schoolchildren from 1996 to 2006 in northern Sweden. J Allergy Clin Immunol 2009; 124:357-63, 63, e1-15; PMID:19577282; http://dx.doi.org/10.1016/j. jaci.2009.05.011.
18. Zeldin Y, Kidon MI, Magen E, Bibi H, Cohen A, Waisel Y, et al. Impact of specific allergen sensitization on the prevalence of asthma in patients with allergic rhinitis from adjacent distinct geographic areas. Ann Allergy Asthma Immunol 2008; 101:30-4; PMID:18681081; http://dx.doi.org/10.1016/S1081- 1206(10)60831-9.
19. Prasad C, Hogan MB, Peele K, Wilson NW. Effect of evaporative coolers on skin test reactivity to dust mites and molds in a desert environment. Allergy Asthma Proc 2009; 30:624-7; PMID:20031008; http://dx.doi. org/10.2500/aap.2009. 30.3290.
20. Sinclair W, Coetzee L, Joubert G. House-dust mite species in Bloemfontein, South Africa. S Afr Med J 2010; 100:164-7; PMID:20459940.
21. Galán I, Prieto A, Rubio M, Herrero T, Cervigón P, Cantero JL, et al. Association between airborne pollen and epidemic asthma in Madrid, Spain: a case-control study. Thorax 2010; 65:398-402; PMID:20435860; http://dx.doi.org/10.1136/thx.2009.118992.
22. Shibasaki M, Tajima K, Morikawa A, Mitsuhashi M, Sumazaki R, Tokuyama K. Relation between frequency of asthma and IgE antibody levels against Dermatophagoides farinae and total serum IgE levels in schoolchildren. J Allergy Clin Immunol 1988; 82:86- 94; PMID:3392374; http://dx.doi.org/10.1016/0091- 6749(88)90056-5.
23. Simpson A, Tan VYF, Winn J, Svensén M, Bishop CM, Heckerman DE, et al. Beyond atopy: multiple patterns of sensitization in relation to asthma in a birth cohort study. Am J Respir Crit Care Med 2010; 181:1200- 6; PMID:20167852; http://dx.doi.org/10.1164/ rccm.200907-1101OC.
24. Turner SW, Heaton T, Rowe J, Suriyaarachchi D, Serralha M, Holt BJ, et al. Early-onset atopy is associated with enhanced lymphocyte cytokine responses in 11-year-old children. Clin Exp Allergy 2007; 37:371- 80; PMID:17359387; http://dx.doi.org/10.1111/ j.1365-2222.2007.02668.x.
25. Gavala ML, Bertics PJ, Gern JE. Rhinoviruses, allergic inflammation, and asthma. Immunol Rev 2011; 242:69-90; PMID:21682739; http://dx.doi. org/10.1111/j.1600-065X.2011.01031.x.
26. Holt PG, Sly PD. Interaction between adaptive and innate immune pathways in the pathogenesis of atopic asthma: operation of a lung/bone marrow axis. Chest 2011; 139:1165-71; PMID:21540215; http://dx.doi. org/10.1378/chest.10- 2397.
27. Almqvist C, Wettermark B, Hedlin G, Ye W, Lundholm C. Antibiotics and asthma medication in a large register- based cohort study - confounding, cause and effect. Clin Exp Allergy 2012; 42:104-11; PMID:22092483; http://dx.doi.org/10.1111/j.1365-2222.2011.03850.x.
28. Hales BJ, Chai LY, Elliot CE, Pearce LJ, Zhang G, Heinrich TK, et al. Antibacterial antibody responses associated with the development of asthma in house dust mite-sensitised and non-sensitised children. Thorax 2012; 67:321-7; PMID:22106019; http:// dx.doi.org/10.1136/thoraxjnl-2011-200650.
29. Van Der Veen MJ, Jansen HM, Aalberse RC, van der Zee JS. Der p 1 and Der p 2 induce less severe late asthmatic responses than native Dermatophagoides pteronyssinus extract after a similar early asthmatic response. Clin Exp Allergy 2001; 31:705-14; PMID:11422129; http://dx.doi.org/10.1046/j.1365-2222.2001. 01120.x.
30. Gøtzsche PC, Johansen HK. House dust mite control measures for asthma. Cochrane Database Syst Rev 2008; CD001187; PMID:18425868.
31. Toelle BG, Ng KK, Crisafulli D, Belousova EG, Almqvist C, Webb K, et al.; Childhood Asthma Prevention Team. Eight-year outcomes of the Childhood Asthma Prevention Study. J Allergy Clin Immunol 2010; 126:388-9, 389, e1-3; PMID:20646752; http:// dx.doi.org/10.1016/j.jaci.2010.04.031.
32. Rijssenbeek-Nouwens LH, Bel EH. High-altitude treatment: a therapeutic option for patients with severe, refractory asthma? Clin Exp Allergy 2011; 41:775-82; PMID:21518039; http://dx.doi.org/10.1111/j.1365- 2222.2011.03733.x.
33. Platts-Mills TA, Tovey ER, Mitchell EB, Moszoro H, Nock P, Wilkins SR. Reduction of bronchial hyperreactivity during prolonged allergen avoidance. Lancet 1982; 2:675-8; PMID:6126624; http://dx.doi. org/10.1016/S0140-6736(82) 90709-7.
34. Groenewoud GC, de Graaf in 't Veld C, vVan Oorschot-van Nes AJ, de Jong NW, Vermeulen AM, van Toorenenbergen AW, et al. Prevalence of sensitization to the predatory mite Amblyseius cucumeris as a new occupational allergen in horticulture. Allergy 2002; 57:614-9; PMID:12100302; http://dx.doi. org/10.1034/j.1398-9995.2002.203511.x.
35. Busse WW, Morgan WJ, Gergen PJ, Mitchell HE, Gern JE, Liu AH, et al. Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children. N Engl J Med 2011; 364:1005-15; PMID:21410369; http://dx.doi.org/10.1056/ NEJMoa1009705.
36. Conner ER, Saini SS. The immunoglobulin E receptor: expression and regulation. Curr Allergy Asthma Rep 2005; 5:191-6; PMID:15842956; http://dx.doi. org/10.1007/s11882-005-0037-5.
37. Pifferi M, Baldini G, Marrazzini G, Baldini M, Ragazzo V, Pietrobelli A, et al. Benefits of immunotherapy with a standardized Dermatophagoides pteronyssinus extract in asthmatic children: a three-year prospective study. Allergy 2002; 57:785-90; PMID:12169173; http:// dx.doi.org/10.1034/j.1398-9995. 2002.23498.x.
38. Varney VA, Tabbah K, Mavroleon G, Frew AJ. Usefulness of specific immunotherapy in patients with severe perennial allergic rhinitis induced by house dust mite: a double-blind, randomized, placebocontrolled trial. Clin Exp Allergy 2003; 33:1076-82; PMID:12911781; http://dx.doi.org/10.1046/j.1365- 2222.2003.01735.x.
39. Bussmann C, Maintz L, Hart J, Allam JP, Vrtala S, Chen KW, et al. Clinical improvement and immunological changes in atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dust mite allergoid: a pilot study. Clin Exp Allergy 2007; 37:1277-85; PMID:17845407; http://dx.doi. org/10.1111/j.1365-2222.2007.02783.x.
40. Larenas-Linnemann DE, Pietropaolo-Cienfuegos DR, Calderón MA. Evidence of effect of subcutaneous immunotherapy in children: complete and updated review from 2006 onward. Ann Allergy Asthma Immunol 2011; 107:407-16, e11; PMID:22018611; http://dx.doi.org/10.1016/j.anai.2011.07.018.
41. Pajno GB, Morabito L, Barberio G, Parmiani S. Clinical and immunologic effects of long-term sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, placebo-controlled study. Allergy 2000; 55:842-9; PMID:11003448; http:// dx.doi.org/10.1034/j.1398-9995.2000.00495.x.
42. O'Hehir RE, Gardner LM, de Leon MP, Hales BJ, Biondo M, Douglass JA, et al. House dust mite sublingual immunotherapy: the role for transforming growth factor-beta and functional regulatory T cells. Am J Respir Crit Care Med 2009; 180:936- 47; PMID:19696440; http://dx.doi.org/10.1164/ rccm.200905-0686OC.
43. Lue KH, Lin YH, Sun HL, Lu KH, Hsieh JC, Chou MC. Clinical and immunologic effects of sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, randomized, placebo-controlled study. Pediatr Allergy Immunol 2006; 17:408-15; PMID:16925685; http://dx.doi.org/10.1111/j.1399- 3038.2006.00443.x.
44. Pham-Thi N, Scheinmann P, Fadel R, Combebias A, Andre C. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures. Pediatr Allergy Immunol 2007; 18:47-57; PMID:17295799; http:// dx.doi.org/10.1111/j.1399-3038.2006.00475.x.
45. Bush RK, Swenson C, Fahlberg B, Evans MD, Esch R, Morris M, et al. House dust mite sublingual immunotherapy: results of a US trial. J Allergy Clin Immunol 2011; 127:974-81, e1-7; PMID:21333346; http:// dx.doi.org/10.1016/j. jaci.2010.11.045.
46. O'Brien RM, Thomas WR. Immune reactivity to Der p I and Der p II in house dust mite sensitive patients attending paediatric and adult allergy clinics. Clin Exp Allergy 1994; 24:737-42; PMID:7982123; http:// dx.doi.org/10.1111/j. 1365-2222.1994.tb00984.x.
47. Des Roches A, Paradis L, Menardo JL, Bouges S, Daurés JP, Bousquet J. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children. J Allergy Clin Immunol 1997; 99:450-3; PMID:9111487; http://dx.doi.org/10.1016/ S0091-6749(97)70069-1.
48. Pajno GB, Barberio G, De Luca F, Morabito L, Parmiani S. Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study. Clin Exp Allergy 2001; 31:1392-7; PMID:11591189; http://dx.doi.org/10.1046/j.1365-2222.2001.01161.x.
49. Harmanci K, Razi CH, Toyran M, Kanmaz G, Cengizlier MR. Evaluation of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. Asian Pac J Allergy Immunol 2010; 28:7-13; PMID:20527510.
50. Purello-D'Ambrosio F, Gangemi S, Merendino RA, Isola S, Puccinelli P, Parmiani S, et al. Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or not. A retrospective study. Clin Exp Allergy 2001; 31:1295-302; PMID:11529901; http://dx.doi.org/10.1046/j.1365- 2222.2001.01027.x.
51. Jacquet A. The role of the house dust miteinduced innate immunity in development of allergic response. Int Arch Allergy Immunol 2011; 155:95-105; PMID:21196753; http://dx.doi. org/10.1159/000320375.
52. Rolland JM, Gardner LM, O'Hehir RE. Functional regulatory T cells and allergen immunotherapy. Curr Opin Allergy Clin Immunol 2010; 10:559- 66; PMID:20859202; http://dx.doi.org/10.1097/ ACI.0b013e32833ff2b2.
53. Larché M. Regulatory T cells in allergy and asthma. Chest 2007; 132:1007-14; PMID:17873195; http:// dx.doi.org/10.1378/chest.06-2434.
54. Tsai YG, Chiou YL, Chien JW, Wu HP, Lin CY. Induction of IL-10+ CD4+ CD25+ regulatory T cells with decreased NF-κB expression during immunotherapy. Pediatr Allergy Immunol 2010; 21:e166-73; PMID:19682278; http://dx.doi.org/10.1111/j.1399- 3038.2009.00870.x.
55. Papadopoulos NG, Xepapadaki P, Mallia P, Brusselle G, Watelet JB, Xatzipsalti M, et al. Mechanisms of virus-induced asthma exacerbations: state-of-theart. A GA2LEN and InterAirways document. Allergy 2007; 62:457-70; PMID:17324199; http://dx.doi. org/10.1111/j.1398-9995.2007.01341.x.
56. Lack G, Nelson HS, Amran D, Oshiba A, Jung T, Bradley KL, et al. Rush immunotherapy results in allergen-specific alterations in lymphocyte function and interferon-gamma production in CD4+ T cells. J Allergy Clin Immunol 1997; 99:530-8; PMID:9111499; http://dx.doi.org/10.1016/S0091- 6749(97)70081-2.
57. Varney VA, Edwards J, Tabbah K, Brewster H, Mavroleon G, Frew AJ. Clinical efficacy of specific immunotherapy to cat dander: a doubleblind placebo-controlled trial. Clin Exp Allergy 1997; 27:860-7; PMID:9291281; http://dx.doi. org/10.1111/j.1365-2222.1997.tb01225.x.
58. Norman PS, Lichtenstein LM. The clinical and immunologic specificity of immunotherapy. J Allergy Clin Immunol 1978; 61:370-7; PMID:77866; http:// dx.doi.org/10.1016/0091-6749(78)90116-1.
59. Marogna M, Spadolini I, Massolo A, Zanon P, Berra D, Chiodini E, et al. Effects of sublingual immunotherapy for multiple or single allergens in polysensitized patients. Ann Allergy Asthma Immunol 2007; 98:274- 80; PMID:17378260; http://dx.doi.org/10.1016/ S1081-1206(10)60718-1.
60. Dreborg S, Lee TH, Kay AB, Durham SR. Immunotherapy is allergen-specific: a double-blind trial of mite or timothy extract in mite and grass dual-allergic patients. Int Arch Allergy Immunol 2012; 158:63-70; PMID:22212720; http://dx.doi. org/10.1159/000330649.
61. Linneberg A, Jacobsen RK, Jespersen L, Abildstrøm SZ. Association of subcutaneous allergen-specific immunotherapy with incidence of autoimmune disease, ischemic heart disease, and mortality. J Allergy Clin Immunol 2012; 129:413-9; PMID:22004944; http:// dx.doi.org/10.1016/j.jaci.2011.09.007.
62. Hirata H, Arima M, Cheng G, Honda K, Fukushima F, Yoshida N, et al. Production of TARC and MDC by naive T cells in asthmatic patients. J Clin Immunol 2003; 23:34-45; PMID:12645858; http://dx.doi. org/10.1023/A: 1021948214742.
63. Wisniewski JA, Borish L. Novel cytokines and cytokine- producing T cells in allergic disorders. Allergy Asthma Proc 2011; 32:83-94; PMID:21439160; http://dx.doi.org/10.2500/aap.2011.32.3428.
64. Thomas WR, Hales BJT. T and B cell responses to HDM allergens and antigens. Immunol Res 2007; 37:187-99; PMID:17873403; http://dx.doi. org/10.1007/BF02697369.
65. O'Brien RM, Thomas WR, Wootton AM. T cell responses to the purified major allergens from the house dust mite Dermatophagoides pteronyssinus. J Allergy Clin Immunol 1992; 89:1021-31; PMID:1583244; http://dx.doi.org/10.1016/0091- 6749(92)90225-Q.
66. Assing K, Nielsen CH, Poulsen LK. Immunological characteristics of subjects with asymptomatic skin sensitization to birch and grass pollen. Clin Exp Allergy 2006; 36:283-92; PMID:16499638; http:// dx.doi.org/10.1111/j.1365- 2222.2006.02435.x.
67. Ford D, Burger D. Precursor frequency of antigen-specific T cells: effects of sensitization in vivo and in vitro. Cell Immunol 1983; 79:334-44; PMID:6191872; http://dx.doi.org/10.1016/0008-8749(83)90075-8.
68. Avanzini MA, Belloni C, Soncini R, Ciardelli L, de Silvestri A, Pistorio A, et al. Increment of recombinant hepatitis B surface antigen-specific T-cell precursors after revaccination of slow responder children. Vaccine 2001; 19:2819-24; PMID:11282192; http://dx.doi. org/10.1016/S0264-410X(01)00007-X.
69. Wambre E, Bonvalet M, Bodo VB, Maillère B, Leclert G, Moussu H, et al. Distinct characteristics of seasonal (Bet v 1) vs. perennial (Der p 1/Der p 2) allergenspecific CD4(+) T cell responses. Clin Exp Allergy 2011; 41:192-203; PMID:21105918; http://dx.doi. org/10.1111/j.1365-2222.2010.03641.x.
70. Parronchi P, Macchia D, Piccinni MP, Biswas P, Simonelli C, Maggi E, et al. Allergen- and bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production. Proc Natl Acad Sci U S A 1991; 88:4538- 42; PMID:1827920; http://dx.doi.org/10.1073/ pnas.88.10.4538.
71. Wierenga EA, Snoek M, Jansen HM, Bos JD, van Lier RA, Kapsenberg ML. Human atopen-specific types 1 and 2 T helper cell clones. J Immunol 1991; 147:2942- 9; PMID:1680923.
72. Hales BJ, Shen H, Thomas WR. Cytokine responses to Der p 1 and Der p 7: house dust mite allergens with different IgE-binding activities. Clin Exp Allergy 2000; 30:934-43; PMID:10848915; http://dx.doi. org/10.1046/j.1365-2222. 2000.00901.x.
73. Bellinghausen I, Brand U, Knop J, Saloga J. Comparison of allergen-stimulated dendritic cells from atopic and nonatopic donors dissecting their effect on autologous naive and memory T helper cells of such donors. J Allergy Clin Immunol 2000; 105:988- 96; PMID:10808181; http://dx.doi.org/10. 1067/ mai.2000.105526.
74. O'Brien RM, Xu H, Rolland JM, Byron KA, Thomas WR. Allergen-specific production of interferon-gamma by peripheral blood mononuclear cells and CD8 T cells in allergic disease and following immunotherapy. Clin Exp Allergy 2000; 30:333-40; PMID:10691890; http://dx.doi.org/10.1046/j.1365-2222.2000.00700.x.
75. Heaton T, Rowe J, Turner S, Aalberse RC, de Klerk N, Suriyaarachchi D, et al. An immunoepidemiological approach to asthma: identification of in-vitro T-cell response patterns associated with different wheezing phenotypes in children. Lancet 2005; 365:142-9; PMID:15639296; http://dx.doi.org/10.1016/ S0140- 6736(05)17704-6.
76. Hollams EM, Deverell M, Serralha M, Suriyaarachchi D, Parsons F, Zhang G, et al. Elucidation of asthma phenotypes in atopic teenagers through parallel immunophenotypic and clinical profiling. J Allergy Clin Immunol 2009; 124:463-70, 470, e1-16; PMID:19733295; http://dx.doi.org/10.1016/j. jaci.2009.06.019.
77. Botturi K, Lacoeuille Y, Cavaillès A, Vervloet D, Magnan A. Differences in allergen-induced T cell activation between allergic asthma and rhinitis: Role of CD28, ICOS and CTLA-4. Respir Res 2011; 12:25; PMID:21356099; http://dx.doi.org/10.1186/1465- 9921-12-25.
78. Byron KA, O'Brien RM, Varigos GA, Wootton AM. Dermatophagoides pteronyssinus II-induced interleukin- 4 and interferon-gamma expression by freshly isolated lymphocytes of atopic individuals. Clin Exp Allergy 1994; 24:878-83; PMID:7812889; http:// dx.doi.org/10.1111/j.1365-2222.1994.tb01810.x.
79. Leonard C, Tormey V, Burke C, Poulter LW. Allergeninduced cytokine production in atopic disease and its relationship to disease severity. Am J Respir Cell Mol Biol 1997; 17:368-75; PMID:9308924.
80. Meiler F, Zumkehr J, Klunker S, Rückert B, Akdis CA, Akdis M. In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure. J Exp Med 2008; 205:2887-98; PMID:19001136; http://dx.doi. org/10.1084/jem.20080193.
81. Oseroff C, Sidney J, Kotturi MF, Kolla R, Alam R, Broide DH, et al. Molecular determinants of T cell epitope recognition to the common Timothy grass allergen. J Immunol 2010; 185:943-55; PMID:20554959; http://dx.doi.org/10.4049/ jimmunol.1000405.
82. Bellinghausen I, König B, Böttcher I, Knop J, Saloga J. Regulatory activity of human CD4 CD25 T cells depends on allergen concentration, type of allergen and atopy status of the donor. Immunology 2005; 116:103-11; PMID:16108822; http://dx.doi. org/10.1111/j.1365-2567.2005.02205.x.
83. Hales BJ, Hazell LA, Smith W, Thomas WR. Genetic variation of Der p 2 allergens: effects on T cell responses and immunoglobulin E binding. Clin Exp Allergy 2002; 32:1461-7; PMID:12372126; http:// dx.doi.org/10.1046/j.1365-2745. 2002.01500.x.
84. Macaubas C, Sly PD, Burton P, Tiller K, Yabuhara A, Holt BJ, et al. Regulation of T-helper cell responses to inhalant allergen during early childhood. Clin Exp Allergy 1999; 29:1223-31; PMID:10469031; http:// dx.doi.org/10.1046/j.1365-2222.1999.00654.x.
85. Matsumoto K, Gauvreau GM, Rerecich T, Watson RM, Wood LJ, O'Byrne PM. IL-10 production in circulating T cells differs between allergen-induced isolated early and dual asthmatic responders. J Allergy Clin Immunol 2002; 109:281-6; PMID:11842298; http://dx.doi.org/10.1067/mai.2002.121144.
86. Akdis M, Verhagen J, Taylor A, Karamloo F, Karagiannidis C, Crameri R, et al. Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J Exp Med 2004; 199:1567- 75; PMID:15173208; http://dx.doi.org/10.1084/ jem.20032058.
87. Hayden CM, Zhang G, Judge PK, Khoo SK, Laing IA, Turner SW, et al. Regulatory role of IL10 genetic variations in determining allergen-induced T(H)2 cytokine responses in children. J Allergy Clin Immunol 2011; 128:237-9, e8; PMID:21439624; http://dx.doi. org/10.1016/j.jaci.2011.02.032.
88. Maggi L, Santarlasci V, Liotta F, Frosali F, Angeli R, Cosmi L, et al. Demonstration of circulating allergenspecific CD4+CD25highFoxp3+ T-regulatory cells in both nonatopic and atopic individuals. J Allergy Clin Immunol 2007; 120:429-36; PMID:17604089; http:// dx.doi.org/10.1016/j.jaci.2007.05.002.
89. Taylor AL, Hale J, Hales BJ, Dunstan JA, Thomas WR, Prescott SL. FOXP3 mRNA expression at 6 months of age is higher in infants who develop atopic dermatitis, but is not affected by giving probiotics from birth. Pediatr Allergy Immunol 2007; 18:10-9; PMID:17295794; http://dx.doi.org/10.1111/j.1399- 3038.2006.00483.x.
90. Lin YL, Shieh CC, Wang JY. The functional insufficiency of human CD4+CD25 high T-regulatory cells in allergic asthma is subjected to TNF-alpha modulation. Allergy 2008; 63:67-74; PMID:18053016; http:// dx.doi.org/10.1111/j. 1398-9995.2007.01526.x.
91. Bullens DM, Truyen E, Coteur L, Dilissen E, Hellings PW, Dupont LJ, et al. IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx? Respir Res 2006; 7:135; PMID:17083726; http://dx.doi.org/10.1186/1465- 9921-7-135.
92. Doe C, Bafadhel M, Siddiqui S, Desai D, Mistry V, Rugman P, et al. Expression of the T helper 17-associated cytokines IL-17A and IL-17F in asthma and COPD. Chest 2010; 138:1140-7; PMID:20538817; http://dx.doi.org/10.1378/ chest.09-3058.
93. Hashimoto T, Akiyama K, Kobayashi N, Mori A. Comparison of IL-17 production by helper T cells among atopic and nonatopic asthmatics and control subjects. Int Arch Allergy Immunol 2005; 137(Suppl 1):51-4; PMID:15947485; http://dx.doi. org/10.1159/000085432.
94. Cosmi L, Maggi L, Santarlasci V, Capone M, Cardilicchia E, Frosali F, et al. Identification of a novel subset of human circulating memory CD4(+) T cells that produce both IL-17A and IL-4. J Allergy Clin Immunol 2010; 125:222-30, e1-4; PMID:20109749; http://dx.doi.org/10.1016/j.jaci.2009.10.012.
95. Hales BJ, Martin AC, Pearce LJ, Laing IA, Hayden CM, Goldblatt J, et al. IgE and IgG anti-house dust mite specificities in allergic disease. J Allergy Clin Immunol 2006; 118:361-7; PMID:16890759; http:// dx.doi.org/10.1016/j.jaci. 2006.04.001.
96. Trombone AP, Tobias KR, Ferriani VP, Schuurman J, Aalberse RC, Smith AM, et al. Use of a chimeric ELISA to investigate immunoglobulin E antibody responses to Der p 1 and Der p 2 in mite-allergic patients with asthma, wheezing and/or rhinitis. Clin Exp Allergy 2002; 32:1323-8; PMID:12220471; http://dx.doi. org/10.1046/j.1365-2745.2002.01455.x.
97. Weghofer M, Dall'Antonia Y, Grote M, Stöcklinger A, Kneidinger M, Balic N, et al. Characterization of Der p 21, a new important allergen derived from the gut of house dust mites. Allergy 2008; 63:758-67; PMID:18445190; http://dx.doi.org/10.1111/j.1398- 9995.2008.01647.x.
98. Kidon MI, Chiang WC, Liew WK, Ong TC, Tiong YS, Wong KN, et al. Mite component-specific IgE repertoire and phenotypes of allergic disease in childhood: the tropical perspective. Pediatr Allergy Immunol 2011; 22:202-10; PMID:21332797; http://dx.doi. org/10.1111/j.1399-3038.2010.01094.x.
99. Thomas WR, Hales BJ, Smith WA. House dust mite allergens in asthma and allergy. Trends Mol Med 2010; 16:321-8; PMID:20605742; http://dx.doi. org/10.1016/j.molmed.2010.04.008.
100. Hales BJ, Martin AC, Pearce LJ, Rueter K, Zhang G, Khoo SK, et al. Anti-bacterial IgE in the antibody responses of house dust mite allergic children convalescent from asthma exacerbation. Clin Exp Allergy 2009; 39:1170-8; PMID:19400897; http://dx.doi. org/10.1111/j.1365-2222.2009.03252.x.
101. Batard T, Hrabina A, Bi XZ, Chabre H, Lemoine P, Couret MN, et al. Production and proteomic characterization of pharmaceutical-grade Dermatophagoides pteronyssinus and Dermatophagoides farinae extracts for allergy vaccines. Int Arch Allergy Immunol 2006; 140:295-305; PMID:16741365; http://dx.doi. org/10.1159/000093707.
102. Miyamoto T, Akiyama K, Ohta K, Urata C, Horiuchi Y. Studies in atopic asthma with emphasis on correlation among various tests and various antibodies. J Allergy Clin Immunol 1981; 67:279-84; PMID:6162873; http://dx.doi.org/10.1016/ 0091-6749(81)90022-1.
103. Chapman MD, Platts-Mills TA. Measurement of IgG, IgA and IgE antibodies to Dermatophagoides pteronyssinus by antigen-binding assay, using a partially purified fraction of mite extract (F4P1). Clin Exp Immunol 1978; 34:126-36; PMID:750116.
104. Aydogan M, Mete N, Yazi D, Akkoc T, Ozdemir C, Blaser K, et al. Comparison of Der p1-specific antibody levels in children with allergic airway disease and healthy controls. Pediatr Allergy Immunol 2007; 18:320-5; PMID:17584311; http://dx.doi. org/10.1111/j.1399-3038.2007.00527.x.
105. Miranda DO, Silva DA, Fernandes JF, Queirós MG, Chiba HF, Ynoue LH, et al. Serum and salivary IgE, IgA, and IgG4 antibodies to Dermatophagoides pteronyssinus and its major allergens, Der p1 and Der p2, in allergic and nonallergic children. Clin Dev Immunol 2011; 2011:302739; PMID:22007250; http://dx.doi. org/10.1155/2011/302739.
106. Tame A, Sakiyama Y, Kobayashi I, Terai I, Kobayashi K. Differences in titres of IgE, IgG4 and other IgG subclass anti-Der p 2 antibodies in allergic and non-allergic patients measured with recombinant allergen. Clin Exp Allergy 1996; 26:43-9; PMID:8789542; http://dx.doi. org/10.1111/j.1365-2222.1996. tb00055.x.
107. Smith AM, Yamaguchi H, Platts-Mills TA, Fu SM. Prevalence of IgG anti-Der p 2 antibodies in children from high and low antigen exposure groups: relationship of IgG and subclass antibody responses to exposure and allergic symptoms. Clin Immunol Immunopathol 1998; 86:102-9; PMID:9434802; http://dx.doi. org/10.1006/clin.1997.4454.
108. Kaur R, Casey JR, Pichichero ME. Serum antibody response to three non-typeable Haemophilus influenzae outer membrane proteins during acute otitis media and nasopharyngeal colonization in otitis prone and non-otitis prone children. Vaccine 2011; 29:1023-8; PMID:21129398; http://dx.doi.org/10.1016/j. vaccine. 2010.11.055.
109. Conrad AJ, Chiang EY, Andeen LE, Avolio C, Walker SM, Baumhefner RW, et al. Quantitation of intrathecal measles virus IgG antibody synthesis rate: subacute sclerosing panencephalitis and multiple sclerosis. J Neuroimmunol 1994; 54:99-108; PMID:7929807; http://dx.doi.org/10.1016/0165-5728(94)90236-4.
110. Oh JH, Hur GY, Ye YM, Kim JE, Park K, Park HS. Correlation between specific IgA and eosinophil numbers in the lavage fluid of patients with perennial allergic rhinitis. Allergy Asthma Proc 2008; 29:152- 60; PMID:18430312; http://dx.doi.org/10.2500/ aap.2008.29.3069.
111. Pilette C, Nouri-Aria KT, Jacobson MR, Wilcock LK, Detry B, Walker SM, et al. Grass pollen immunotherapy induces an allergen-specific IgA2 antibody response associated with mucosal TGF-beta expression. J Immunol 2007; 178:4658-66; PMID:17372025.
112. Yasueda H, Mita H, Yui Y, Shida T. Comparative analysis of physicochemical and immunochemical properties of the two major allergens from Dermatophagoides pteronyssinus and the corresponding allergens from Dermatophagoides farinae. Int Arch Allergy Appl Immunol 1989; 88:402-7; PMID:2498214; http:// dx.doi.org/10.1159/000234724.
113. Heymann PW, Chapman MD, Platts-Mills TA. Antigen Der f I from the dust mite Dermatophagoides farinae: structural comparison with Der p I from Dermatophagoides pteronyssinus and epitope specificity of murine IgG and human IgE antibodies. J Immunol 1986; 137:2841-7; PMID:2428875.
114. Heymann PW, Chapman MD, Aalberse RC, Fox JW. Platts-MIlls TAE. Antigenic and structural analysis of group II allergens (Der f II and Der p II) from dust mites (Dermatophagoides spp). J Allergy Clin Immunol 1989; 83:1055-67; PMID:2732406; http:// dx.doi.org/10.1016/0091-6749(89)90447-8.
115. Shen HD, Chua KY, Lin WL, Hsieh KH, Thomas WR. Molecular cloning and immunological characterization of the house dust mite allergen Der f 7. Clin Exp Allergy 1995; 25:1000-6; PMID:8556554; http:// dx.doi.org/10.1111/j.1365-2222. 1995.tb00403.x.
116. Hales BJ, Shen HD, Thomas WR. Cross-reactivity of T-cell responses to Dermatophagoides pteronyssinus and D. farinae. Studies with group 1 and 7 allergens. Clin Exp Allergy 2000; 30:927-33; PMID:10848914; http://dx.doi.org/ 10.1046/j.1365-2222.2000.00900.x.
117. Hales BJ, Thomas WR. T-cell sensitization to epitopes from the house dust mites Dermatophagoides pteronyssinus and Euroglyphus maynei. Clin Exp Allergy 1997; 27:868-75; PMID:9291282; http:// dx.doi.org/10.1111/j.1365-2222.1997. tb01226.x.
118. Moscato G, Rossi G, Dellabianca A, Pisati A, Vinci G, Biale C. Local immunotherapy by inhalation of a powder extract in asthma due to house dust mite Dermatophagoides pteronyssinus: a doubleblind comparison with parenteral immunotherapy. J Investig Allergol Clin Immunol 1991; 1:383-94; PMID:1669598.
119. Shim JY, Kim BS, Cho SH, Min KU, Hong SJ. Allergen-specific conventional immunotherapy decreases immunoglobulin E-mediated basophil histamine releasability. Clin Exp Allergy 2003; 33:52-7; PMID:12534549; http://dx.doi.org/10.1046/j.1365- 2222.2003.01567.x.
120. Maestrelli P, Zanolla L, Pozzan M, Fabbri LM; Regione Veneto Study Group on the "Effect of immunotherapy in allergic asthma". Effect of specific immunotherapy added to pharmacologic treatment and allergen avoidance in asthmatic patients allergic to house dust mite. J Allergy Clin Immunol 2004; 113:643- 9; PMID:15100667; http://dx.doi.org/10.1016/j. jaci.2003.12.586.
121. Cheong N, Ramos JD, Tang CY, Chng HH, Yao R, Liang Z, et al. Mite amylase from Blomia tropicalis (Blo t 4): differential allergenicity linked to geographical regions. Int Arch Allergy Immunol 2009; 149:25-32; PMID:19033729; http://dx.doi. org/10.1159/000176303.
122. Fernández-Caldas E, Baena-Cagnani CE, López M, Patiño C, Neffen HE, Sánchez-Medina M, et al. Cutaneous sensitivity to six mite species in asthmatic patients from five Latin American countries. J Investig Allergol Clin Immunol 1993; 3:245-9; PMID:8298748.
123. Acevedo N, Sánchez J, Erler A, Mercado D, Briza P, Kennedy M, et al. IgE cross-reactivity between Ascaris and domestic mite allergens: the role of tropomyosin and the nematode polyprotein ABA-1. Allergy 2009; 64:1635-43; PMID:19624559; http://dx.doi. org/10.1111/j.1398-9995.2009.02084.x.
124. Shen HD, Tam MF, Tang RB, Chou H. Aspergillus and Penicillium allergens: focus on proteases. Curr Allergy Asthma Rep 2007; 7:351-6; PMID:17697643; http:// dx.doi.org/10.1007/s11882-007-0053-8.
125. Shakib F, Ghaemmaghami AM, Sewell HF. The molecular basis of allergenicity. Trends Immunol 2008; 29:633-42; PMID:18951844; http://dx.doi. org/10.1016/j.it.2008.08.007.
126. Donnelly S, O'Neill SM, Stack CM, Robinson MW, Turnbull L, Whitchurch C, et al. Helminth cysteine proteases inhibit TRIF-dependent activation of macrophages via degradation of TLR3. J Biol Chem 2010; 285:3383-92; PMID:19923225; http://dx.doi. org/10.1074/jbc.M109.060368.
127. Yan Z, Banerjee R. Redox remodeling as an immunoregulatory strategy. Biochemistry 2010; 49:1059- 66; PMID:20070126; http://dx.doi.org/10.1021/ bi902022n.
128. Ichikawa S, Takai T, Yashiki T, Takahashi S, Okumura K, Ogawa H, et al. Lipopolysaccharide binding of the mite allergen Der f 2. Genes Cells 2009; 14:1055-65; PMID:19678854; http://dx.doi.org/10.1111/j.1365- 2443.2009.01334.x.
129. Trompette A, Divanovic S, Visintin A, Blanchard C, Hegde RS, Madan R, et al. Allergenicity resulting from functional mimicry of a Toll-like receptor complex protein. Nature 2009; 457:585-8; PMID:19060881; http://dx.doi.org/10. 1038/nature07548.
130. Thomas WR. Molecular mimicry as the key to the dominance of the house dust mite allergen Der p 2. Expert Rev Clin Immunol 2009; 5:233-7; PMID:20477001; http://dx.doi.org/10.1586/eci.09.5.
131. Mueller GA, Edwards LL, Aloor JJ, Fessler MB, Glesner J, Pomés A, et al. The structure of the dust mite allergen Der p 7 reveals similarities to innate immune proteins. J Allergy Clin Immunol 2010; 125:909- 17, e4; PMID:20226507; http://dx.doi.org/10.1016/j. jaci.2009.12.016.
132. Shen HD, Tam MF, Huang CH, Chou H, Tai HY, Chen YS, et al. Homology modeling and monoclonal antibody binding of the Der f 7 dust mite allergen. Immunol Cell Biol 2011; 89:225-30; PMID:20567249; http://dx.doi.org/10.1038/icb. 2010.77.
133. Smith W, O'Neil SE, Hales BJ, Chai TL, Hazell LA, Tanyaratsrisakul S, et al. Two newly identified cat allergens: the von Ebner gland protein Fel d 7 and the latherin-like protein Fel d 8. Int Arch Allergy Immunol 2011; 156:159-70; PMID:21576986; http://dx.doi. org/10.1159/000322879.
134. Mueller GA, Gosavi RA, Krahn JM, Edwards LL, Cuneo MJ, Glesner J, et al. Der p 5 crystal structure provides insight into the group 5 dust mite allergens. J Biol Chem 2010; 285:25394-401; PMID:20534590; http://dx.doi.org/10.1074/jbc. M110.128306.
135. Naik MT, Chang CF, Kuo IC, Yu T, Fang PJ, Chua KY, et al. Complete 1H, 13C and 15N resonance assignments of Blo t 5, a major mite allergen from Blomia tropicalis. J Biomol NMR 2007; 38:189; PMID:17206470; http://dx.doi.org/10.1007/ s10858- 006-9113-y.
136. Chan SL, Ong TC, Gao YF, Tiong YS, Wang Y, Chew FT, et al. Nuclear magnetic resonance structure and IgE epitopes of Blo t 5, a major dust mite allergen. J Immunol 2008; 181:2586-96; PMID:18684949.
137. Satinover SM, Reefer AJ, Pomes A, Chapman MD, Platts-Mills TA, Woodfolk JA. Specific IgE and IgG antibody-binding patterns to recombinant cockroach allergens. J Allergy Clin Immunol 2005; 115:803- 9; PMID:15806002; http://dx.doi.org/10.1016/j. jaci.2005.01.018.
138. Resch Y, Weghofer M, Seiberler S, Horak F, Scheiblhofer S, Linhart B, et al. Molecular characterization of Der p 10: a diagnostic marker for broad sensitization in house dust mite allergy. Clin Exp Allergy 2011; 41:1468-77; PMID:21711470; http://dx.doi.org/10.1111/j.1365- 2222.2011.03798.x.
139. Aki T, Kodama T, Fujikawa A, Miura K, Shigeta S, Wada T, et al. Immunochemical characterization of recombinant and native tropomyosins as a new allergen from the house dust mite, Dermatophagoides farinae. J Allergy Clin Immunol 1995; 96:74-83; PMID:7622766; http://dx.doi.org/10.1016/S0091- 6749(95)70035-8.
140. Westritschnig K, Sibanda E, Thomas W, Auer H, Aspöck H, Pittner G, et al. Analysis of the sensitization profile towards allergens in central Africa. Clin Exp Allergy 2003; 33:22-7; PMID:12534545; http:// dx.doi.org/10.1046/j.1365-2222.2003.01540.x.
141. Hales BJ, Laing IA, Pearce LJ, Hazell LA, Mills KL, Chua KY, et al. Distinctive immunoglobulin E antihouse dust allergen-binding specificities in a tropical Australian Aboriginal community. Clin Exp Allergy 2007; 37:1357-63; PMID:17845417; http://dx.doi. org/10.1111/j.1365-2222.2007.02786.x.
142. Sookrung N, Chaicumpa W, Tungtrongchitr A, Vichyanond P, Bunnag C, Ramasoota P, et al. Periplaneta americana arginine kinase as a major cockroach allergen among Thai patients with major cockroach allergies. Environ Health Perspect 2006; 114:875-80; PMID:16759988; http://dx.doi. org/10.1289/ehp.8650.
143. García-Orozco KD, Aispuro-Hernández E, Yepiz-Plascencia G, Calderón-de-la-Barca AM, Sotelo-Mundo RR. Molecular characterization of arginine kinase, an allergen from the shrimp Litopenaeus vannamei. Int Arch Allergy Immunol 2007; 144:23-8; PMID:17496423; http://dx.doi. org/10.1159/000102610.
144. von Mutius E, Drazen JM. A patient with asthma seeks medical advice in 1828, 1928, and 2012. N Engl J Med 2012; 366:827-34; PMID:22375974; http://dx.doi. org/10.1056/NEJMra1102783.
145. Brightling CE, Gupta S, Hollins F, Sutcliffe A, Amrani Y. Immunopathogenesis of severe asthma. Curr Pharm Des 2011; 17:667-73; PMID:21406060; http://dx.doi. org/10.2174/138161211795429028.
146. Fuhrman C, Dubus JC, Marguet C, Delacourt C, Thumerelle C, de Blic J, et al. Hospitalizations for asthma in children are linked to undertreatment and insufficient asthma education. J Asthma 2011; 48:565- 71; PMID:21595608; http://dx.doi.org/10.3109/0277 0903.2011.580031.
147. Kandane-Rathnayake RK, Matheson MC, Simpson JA, Tang ML, Johns DP, Mészáros D, et al. Adherence to asthma management guidelines by middle-aged adults with current asthma. Thorax 2009; 64:1025- 31; PMID:19703827; http://dx.doi.org/10.1136/ thx.2009.118430.
148. Tovey ER, Marks GB. It's time to rethink mite allergen avoidance. J Allergy Clin Immunol 2011; 128:723- 7, e6; PMID:21855978; http://dx.doi.org/10. 1016/j. jaci.2011.07.009.
149. Norman PS, Winkenwerder WL, Lichtenstein LM. Immunotherapy of hay fever with ragweed antigen E: comparisons with whole pollen extract and placebos. J Allergy 1968; 42:93-108; PMID:4873833; http:// dx.doi.org/10.1016/0021-8707(68) 90139-1.
150. Gadermaier G, Wopfner N, Wallner M, Egger M, Didierlaurent A, Regl G, et al. Array-based profiling of ragweed and mugwort pollen allergens. Allergy 2008; 63:1543-9; PMID:18925891; http://dx.doi. org/10.1111/j.1398-9995.2008.01780.x.
151. Francis JN, James LK, Paraskevopoulos G, Wong C, Calderon MA, Durham SR, et al. Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity. J Allergy Clin Immunol 2008; 121:1120- 5, e2; PMID:18374405; http://dx.doi.org/10.1016/j. jaci.2008.01.072.
152. Möbs C, Slotosch C, Löffler H, Jakob T, Hertl M, Pfützner W. Birch pollen immunotherapy leads to differential induction of regulatory T cells and delayed helper T cell immune deviation. J Immunol 2010; 184:2194-203; PMID:20048125; http://dx.doi. org/10.4049/jimmunol.0901379.
153. James LK, Shamji MH, Walker SM, Wilson DR, Wachholz PA, Francis JN, et al. Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies. J Allergy Clin Immunol 2011; 127:509-16, e1-5; PMID:21281875; http://dx.doi.org/10.1016/j.jaci.2010.12.1080.
154. Würtzen PA, Lund G, Lund K, Arvidsson M, Rak S, Ipsen H. A double-blind placebo-controlled birch allergy vaccination study II: correlation between inhibition of IgE binding, histamine release and facilitated allergen presentation. Clin Exp Allergy 2008; 38:1290-301; PMID:18510696; http://dx.doi.org/10.1111/j.1365- 2222.2008.03020.x.
155. van Neerven RJ, Wikborg T, Lund G, Jacobsen B, Brinch-Nielsen A, Arnved J, et al. Blocking antibodies induced by specific allergy vaccination prevent the activation of CD4+ T cells by inhibiting serum-IgEfacilitated allergen presentation. J Immunol 1999; 163:2944-52; PMID:10453043.
156. Walker SM, Durham SR, Till SJ, Roberts G, Corrigan CJ, Leech SC, et al.; British Society for Allergy and Clinical Immunology. Immunotherapy for allergic rhinitis. Clin Exp Allergy 2011; 41:1177-200; PMID:21848757; http://dx.doi.org/10.1111/j.1365- 2222.2011.03794.x.
157. Campbell JD, Buchmann P, Kesting S, Cunningham CR, Coffman RL, Hessel EM. Allergen-specific T cell responses to immunotherapy monitored by CD154 and intracellular cytokine expression. Clin Exp Allergy 2010; 40:1025-35; PMID:20412135; http://dx.doi. org/10.1111/j.1365-2222.2010.03505.x.